IP Verse

Sclerostin Binding Agents - EP3670528

The patent EP3670528 was granted to Amgen on Sep 8, 2021. The application was originally filed on Apr 28, 2006 under application number EP19211623A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3670528

AMGEN
Application Number
EP19211623A
Filing Date
Apr 28, 2006
Status
Granted And Under Opposition
Aug 6, 2021
Grant Date
Sep 8, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

JAMES POOLEJun 7, 2022CARPMAELS & RANSFORDWITHDRAWN

Patent Citations (42) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS20070868497
DESCRIPTIONUS2004009535
DESCRIPTIONUS2004146888
DESCRIPTIONUS2005106683
DESCRIPTIONUS2005238646
DESCRIPTIONUS4179337
DESCRIPTIONUS4301144
DESCRIPTIONUS4331647
DESCRIPTIONUS4411993
DESCRIPTIONUS4464456
DESCRIPTIONUS4496689
DESCRIPTIONUS4543439
DESCRIPTIONUS4640835
DESCRIPTIONUS4670417
DESCRIPTIONUS4791192
DESCRIPTIONUS4902614
DESCRIPTIONUS5145684
DESCRIPTIONUS5223409
DESCRIPTIONUS5399363
DESCRIPTIONUS5466468
DESCRIPTIONUS5543158
DESCRIPTIONUS5552157
DESCRIPTIONUS5565213
DESCRIPTIONUS5567434
DESCRIPTIONUS5627052
DESCRIPTIONUS5641515
DESCRIPTIONUS5698426
DESCRIPTIONUS5738868
DESCRIPTIONUS5795587
DESCRIPTIONUS5877397
DESCRIPTIONUS6133426
DESCRIPTIONUS6395511
DESCRIPTIONUS6703199
DESCRIPTIONUS6803453
DESCRIPTIONUSRE32011E
DESCRIPTIONWO9202551
OPPOSITIONEP1636270
OPPOSITIONWO0032773
OPPOSITIONWO2005003158
OPPOSITIONWO2005014650
SEARCHWO2005003158
SEARCHWO2005014650

Non-Patent Literature (NPL) Citations (86) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- ALTING-MEES et al., Strategies in Molecular Biology, (19900000), vol. 3, pages 1 - 9
DESCRIPTION- ANGAL S et al., Mol Immunol, (19930000), vol. 30, no. 1, pages 105 - 108
DESCRIPTION- BABCOOK et al., Proc. Natl. Acad. Sci. USA, (19960000), vol. 93, pages 7843 - 48
DESCRIPTION- BALEMANS et al., Hum. Mol. Genet., (20010000), vol. 10, pages 537 - 543
DESCRIPTION- BIRD et al., Science, (19880000), vol. 242, pages 423 - 426
DESCRIPTION- BOERNER et al., J. Immunol., (19910000), vol. 147, pages 86 - 95
DESCRIPTION- Bone and Mineral, (19910000), vol. 15, pages 175 - 192
DESCRIPTION- BOWIE et al., Science, (19910000), vol. 253, pages 164 - 170
DESCRIPTION- BRENNER et al., Curr. Op. Struct. Biol., (19970000), vol. 7, no. 3, pages 369 - 376
DESCRIPTION- BRUGGEMANN et al., Curro Opin. Biotechnol., (19970000), vol. 8, pages 455 - 58
DESCRIPTION- BRUGGEMANN et al., Curr. Opin. Biotechnol., (19970000), vol. 8, pages 455 - 733
DESCRIPTION- BRUNKOW et al., Am. J. Hum. Genet., (20010000), vol. 68, pages 577 - 589
DESCRIPTION- BURTON et al., Adv. Immunol., (19940000), vol. 57, pages 191 - 280
DESCRIPTION- BYRNE, F. R. et al., Gut, (20050000), vol. 54, pages 78 - 86
DESCRIPTION- CHANDRAN et al., Indian J. Exp. Biol., (19970000), vol. 35, no. 8, pages 801 - 09
DESCRIPTION- CHOU et al., Adv. Enzymol. Relat. Areas Mol. Biol., (19780000), vol. 47, pages 45 - 148
DESCRIPTION- CHOU et al., Ann. Rev. Biochem., vol. 47, pages 251 - 276
DESCRIPTION- CHOU et al., Biochemistry, (19740000), vol. 113, no. 2, pages 211 - 222
DESCRIPTION- CHOU et al., Biophys. J., (19790000), vol. 26, pages 367 - 384
DESCRIPTION- CLARK, M., Immunology Today, (20000000), vol. 21, no. 8, pages 397 - 402
DESCRIPTION- COMIER, Curr. Opin. in Rheu., (19950000), vol. 7, page 243
DESCRIPTION- COUVREUR et al., Crit. Rev. Ther. Drug Carrier Syst., (19880000), vol. 5, no. 1, pages 1 - 20
DESCRIPTION- CRAMERI et al., Nature, (19980000), vol. 391, pages 288 - 291
DESCRIPTION- DALL'ACQUA WF et al., Methods, (20050000), vol. 36, no. 1, pages 3 5 - 60
DESCRIPTION- EDELMAN, Methods in Enzymology, Academic Press, (19670000), vol. 1, page 422
DESCRIPTION- "Genetic Manipulation and Expression of Antibodies", WARD et al., Monoclonal Antibodies: Principles and Applications, Wiley-Liss, Inc., (19950000), page 137
DESCRIPTION- "Genetic Manipulation of Monoclonal Antibodies", COURTENAY-LUCK et al., Monoclonal Antibodies: Production, Engineering and Clinical Application, Cambridge University Press, (19950000), page 166
DESCRIPTION- GLASKY et al., Hybridoma, (19890000), vol. 8, pages 377 - 89
DESCRIPTION- GREEN et al., Nature Genet., (19940000), vol. 7, page 13
DESCRIPTION- GRIBSKOV et al., Meth. Enzym., (19900000), vol. 183, pages 146 - 159
DESCRIPTION- GRIBSKOV et al., Proc. Nat. Acad. Sci., (19870000), vol. 84, no. 13, pages 4355 - 4358
DESCRIPTION- GUINNESS-HEY, Metab. Bone Dis. Relat. Res., (19840000), vol. 5, pages 177 - 181
DESCRIPTION- HARRIS, RJ., Journal of Chromatography, (19950000), vol. 705, pages 129 - 134
DESCRIPTION- HOLLINGERHUDSON, Nature Biotechnology, (20050000), vol. 23, no. 9, pages 1126 - 1136
DESCRIPTION- HOLM et al., Nucl. Acid. Res., (19990000), vol. 27, no. 1, pages 244 - 247
DESCRIPTION- HOOGENBOOM et al., J. Molec. Biol., (19920000), vol. 227, pages 381 - 388
DESCRIPTION- HUSE et al., Science, (19890000), vol. 246, pages 1275 - 81
DESCRIPTION- JAKOBOVITS et al., Ann. N. Y. Acad. Sci., (19950000), vol. 764, pages 525 - 35
DESCRIPTION- JEE, W.S.S.YAO, W., "Overview: animal models of osteopenia and osteoporosis", J. Musculoskel. Neuron. Interact., (20010000), vol. 1, pages 193 - 207, XP055573206
DESCRIPTION- JONES, D., Curr. Opin. Struct. Biol., (19970000), vol. 7, no. 3, pages 377 - 87
DESCRIPTION- KANG et al., Proc. Natl. Acad. Sci. USA, (19910000), vol. 88, pages 4363 - 66
DESCRIPTION- KHOSLARIGGS, Mayo Clin. Proc., (19950000), vol. 70, page 978982
DESCRIPTION- KOHLER et al., Nature, (19750000), vol. 256, page 495
DESCRIPTION- KRAMER et al., Nucleic Acids Res., (19840000), vol. 12, page 9441
DESCRIPTION- KUNKEL et al., Methods in Enzymol., (19870000), vol. 154, pages 367 - 82
DESCRIPTION- KUNKEL, Proc. Natl. Acad. Sci. USA, (19850000), vol. 82, pages 488 - 92
DESCRIPTION- LARRICK et al., Methods: A Companion to Methods in Enzymology, (19910000), vol. 2, page 106
DESCRIPTION- LASIC, Trends Biotechnol., (19980000), vol. 16, no. 7, pages 1035 - 1038,1570-1580
DESCRIPTION- LONBERG et al., Nature, (19940000), vol. 368, page 856
DESCRIPTION- MARGALIT, Crit. Rev. Ther. Drug Carrier Syst., (19950000), vol. 12, no. 2-3, pages 233 - 61
DESCRIPTION- MARKS et al., Bio/Technology, (19920000), vol. 10, pages 779 - 783
DESCRIPTION- MOULT J., Curr. Op. in Biotech., (19960000), vol. 7, no. 4, pages 422 - 427
DESCRIPTION- MUHLEN et al., Eur. J. Pharm. Biopharm., (19980000), vol. 45, no. 2, pages 149 - 55
DESCRIPTION- NISONOFF et al., Arch. Biochem. Biophys., (19600000), vol. 89, page 230
DESCRIPTION- NYGRENUHLEN, Current Opinion in Structural Biology, (19970000), vol. 7, pages 463 - 469
DESCRIPTION- PLUCKTHUN et al., Methods Enzymol., (19890000), vol. 178, pages 497 - 515
DESCRIPTION- PORTER, Biochem. J., (19590000), vol. 73, page 119
DESCRIPTION- "Production of monoclonal antibodies against proteins expressed", PICKSLEY et al., E. coli,'' in DNA Cloning 2: Expression Systems, Oxford University Press, (19950000), page 93
DESCRIPTION- "Purification of Immunoglobulin G (IgG", BAINES et al., Methods in Molecular Biology, The Humana Press, Inc., (19920000), vol. 10, pages 79 - 104
DESCRIPTION- QUINTANAR-GUERRERO et al., Drug Dev. Ind. Pharm., (19980000), vol. 24, no. 12, pages 1113 - 28
DESCRIPTION- RIGGS, West J. Med., (19910000), vol. 154, pages 63 - 77
DESCRIPTION- SANGER et al., PNAS, (19770000), vol. 74, page 5463
DESCRIPTION- SASTRY et al., Proc. Natl. Acad. Sci. USA, (19890000), vol. 86, pages 5728 - 32
DESCRIPTION- SCATCHARD et al., Ann. N.Y. Acad. Sci., (19490000), vol. 51, pages 660 - 672
DESCRIPTION- SCHLEBUSCH et al., Hybridoma, (19970000), vol. 16, pages 47 - 52
DESCRIPTION- SIPPL et al., Structure, (19960000), vol. 4, no. 1, pages 15 - 19
DESCRIPTION- SMITH EREDMAN RLOGG CCOETZEE GKASAHARA NFRENKEL B, "Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle", J Biol Chem, (20000000), vol. 275, pages 19992 - 20001
DESCRIPTION- SMITH EREDMAN RLOGG CCOETZEE GKASAHARA NFRENKEL B., "Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle", J. Biol. Chem., (20000000), vol. 275, pages 19992 - 20001
DESCRIPTION- TAKAKURA, Nippon Rinsho, (19980000), vol. 56, no. 3, pages 691 - 95
DESCRIPTION- TAYLOR et al., Int. Immun., (19940000), vol. 6, page 579
DESCRIPTION- THOMPSON et al., J. Mol. Biol., (19960000), vol. 256, pages 350 - 368
DESCRIPTION- THORNTON et al., Nature, (19910000), vol. 354, page 105
DESCRIPTION- VAUGHAN et al., Nature Biotechnology, (19980000), vol. 16, pages 535 - 539
DESCRIPTION- WINTER et al., Annu. Rev. Immunol., (19940000), vol. 12, pages 433 - 55
DESCRIPTION- WOLFF et al., Cancer Res., (19930000), vol. 53, pages 2560 - 65
DESCRIPTION- YANG et al., J. Mol. Biol., (19950000), vol. 254, pages 392 - 403
DESCRIPTION- ZAMBAUX et al., J. Controlled Release, (19980000), vol. 50, no. 1-3, pages 31 - 40
DESCRIPTION- ZHANG, W. et al., Molecular Immunology., (20050000), vol. 42, no. 12, pages 1445 - 1451
DESCRIPTION- FROST, H.M.JEE, W.S.S., "On the rat model of human osteopenias andosteoporosis", Bone and Mineral, (19920000), vol. 18, doi:10.1016/0169-6009(92)90809-R, pages 227 - 236, XP023072088
DESCRIPTION- SUDO H et al., "In vitro differentiation and calcification in a new clonal osteogenic cell line derivedfrom newborn mouse calvaria", J. Cell Biol., vol. 96, doi:10.1083/jcb.96.1.191, pages 191 - 198, XP002000687
DESCRIPTION- SUDO HKODAMA H-AAMAGAI YYAMAMOTO SKASAI S, "In vitro differentiation and calcification in a new clonal osteogenic cell line derivedfrom newborn mouse calvaria", J Cell Biol, (19830000), vol. 96, doi:10.1083/jcb.96.1.191, pages 191 - 198, XP002000687
DESCRIPTION- SUDO HKODAMA H-AAMAGAI YYAMAMOTO SKASAI S, "In vitro differentiation and calcification in a new clonal osteogenic cell line derivedfrom newborn mouse calvaria", J. Cell Biol., (19830000), vol. 96, doi:10.1083/jcb.96.1.191, pages 191 - 198, XP002000687
OPPOSITION- BEZOOIJEN VAN R L, ET AL, "Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist.", Journal of Experimental Medicine, US , (20040315), vol. 199, no. 6, doi:10.1084/jem.20031454, ISSN 0022-1007, pages 805 - 814, XP002391779
OPPOSITION- WARMINGTON et al., "SCIEROSTIN ANTAGONISM IN ADULT RODENTS, VIA MONOCLONAL ANTIBODY MEDIATED BLOCKADE, INCREASES BONE MINERAL DENSITY AND IMPLICATES SCLEROSTIN AS A KEY REGULATOR OF BONE MASS DURING ADULTHOOD", Journal of Bone and Mineral Research, US , (20041005), vol. 19, doi:10.1359/JBMR.0301211, ISSN 0884-0431, pages S56 - S57, XP009072609
SEARCH- AVSIAN-KRETCHMER ORNA ET AL, "Comparative genomic analysis of the eight-membered ring cystine knot-containing bone morphogenetic protein antagonists.", MOLECULAR ENDOCRINOLOGY (BALTIMORE, MD.) JAN 2004, (200401), vol. 18, no. 1, ISSN 0888-8809, pages 1 - 12, XP002400896 [A] 1-7 * the whole document *
SEARCH- WARMINGTON K ET AL, "Scierostin antagonism in adult rodents, via monoclonal antibody mediated blockade, increases bone mineral density and implicates sclerostin as a key regulator of bone mass during adulthood", JOURNAL OF BONE AND MINERAL RESEARCH, & 26TH ANNUAL MEETING OF THE AMERICAN-SOCIETY-FOR-BONE-AND-MINERAL-RESE ARCH; SEATTLE, WA, USA; OCTOBER 01 -05, 2004, (200410), vol. 19, ISSN 0884-0431, pages S56 - S57, XP009072609 [Y] 1-7 * abstract *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents